12 Biggest Mid-Day Gainers For Friday - Aldeyra Therapeutics (NASDAQ:ALDX), AEterna Zentaris (NASDAQ:AEZS)

Stone Energy Corporation SGY shares surged 16.7 percent to $14.07. Stone Energy shares have dropped 88.55 percent over the past 52 weeks, while the S&P 500 index has gained 1.45 percent in the same period.
Aldeyra Therapeutics Inc ALDX shares jumped 12.7 percent to $6.41. Stifel Nicolaus initiated coverage of Aldeyra Therapeutics with a Buy rating.
AEterna Zentaris Inc. (USA) AEZS shares climbed 12.3 percent to $3.66 as the company reported that it has signed an exclusive license agreement with Cyntec, an affiliate of Orient EuroPharma Co, for Zoptrex.
Kinross Gold Corporation (USA) KGC gained 6.8 percent to $5.22. Macquarie upgraded Kinross Gold from Underperform to Neutral.
Thor Industries, Inc. THO shares gained 6.6 percent to $69.04 after the company disclosed the acquisition of Jayco, Corp. for about $576 million in cash.
Mesoblast limited (ADR) MESO shares rose 5.6 percent to $4.21 after the company issued an update on heart failure trial and funding of clinical operations. Mesoblast projects to do interim analysis for Phase 3 endpoints in Q1 2017
Netflix, Inc. NFLX gained 5.5 percent to $96.45. Canaccord Genuity initiated coverage on Netflix with a Buy rating and a $120.00 price target.
Harmony Gold Mining Co. (ADR) HMY rose 5.3 percent to $3.80. Macquarie upgraded Harmony Gold Mining from Underperform to Neutral.
Pan American Silver Corp. (USA) PAAS shares gained 4.4 percent to $17.17. Silver futures gained 4.6 percent to trade at $19.49 an ounce.
Randgold Resources Ltd. (ADR) GOLD gained 4.3 percent to $116.78. Macquarie upgraded Randgold from Neutral to Outperform. Gold futures gained 1.4 percent to $1,338.90 an ounce.
Galectin Therapeutics Inc GALT shares rose 3.4 percent to $1.52. Roth Capital assumed Galectin Therapeutics with a Buy rating.
Array Biopharma Inc ARRY shares rose 3.1 percent to $3.67 after the company reported the submission of NDA for binimetinib to the FDA.

Market News and Data brought to you by Benzinga APIs